Search

Jay L Duffner

from Shirley, MA
Age ~46
Get Report
Also known as:
Jay Lawrence Duffner, Jay L Doffner, Jay Lawrence
Phone and address:
27 Lawton Rd, Shirley, MA 01464
Connected to:
Jera Duffney, 42Kevin T Duffney, 49Kim E Duffney, 60Lisa Duffney, 47Robert S Duffney, 82Carlos D Duffoo, 65John M Duffoo, 52Charles W Dufford, 67Daryle A Dufford, 56Garry D Dufford, 56

Jay Duffner Phones & Addresses

  • 27 Lawton Rd, Shirley, MA 01464
  • 29 Lawton Rd, Shirley, MA 01464
  • Arlington, MA
  • Milford, CT
  • 17 Eaton St, Winchester, MA 01890 (781) 369-1015
  • Somerville, MA
  • Dorchester Center, MA
  • Medford, MA

Resumes

Resumes

Jay Duffner Photo 1

Principal Scientist

View page
Location:
29 Lawton Rd, Shirley, MA 01464
Industry:
Biotechnology
Work:
Momenta Pharmaceuticals
Principal Scientist
Broad Institute Dec 2004 - Nov 2006
Research Associate Ii
Momenta Pharmaceuticals Dec 2004 - Nov 2006
Senior Scientist
Mykrolis Corporation Mar 2001 - Apr 2004
Applications Engineer Ii
Takeda Oncology Jun 1999 - Mar 2001
Intern
Education:
Boston University 2008 - 2009
Northeastern University 2005 - 2008
Master of Science, Masters, Biotechnology Tufts University Sep 1, 1997 - 2001
Bachelors, Bachelor of Science, Chemical Engineering
Skills:
Biotechnology
Assay Development
Protein Chemistry
Elisa
Molecular Biology
Cell
Qpcr
Drug Discovery
High Throughput Screening
Rt Pcr
R
Statistics
Oncology
Lifesciences
Microarray
Immunoassays
Laboratory Automation
Project Management
Life Sciences
Cell Biology
Real Time Polymerase Chain Reaction
Sharepoint
Linear Regression
R Package Development
Surface Plasmon Resonance
Crispr
Principal Component Analysis
Microarray Analysis
Electronic Laboratory Notebook
Interests:
Hiking
Soccer
Science History
Cycling
Jay Duffner Photo 2

Jay Duffner

View page
Position:
Senior Scientist at Momenta Pharmaceuticals
Location:
Greater Boston Area
Industry:
Biotechnology
Work:
Momenta Pharmaceuticals - Cambridge, MA since Nov 2006
Senior Scientist
Broad Institute Dec 2004 - Nov 2006
Research Associate II
Mykrolis Corporation Mar 2001 - Apr 2004
Applications Engineer II
Millennium Pharmaceuticals Jun 1999 - Mar 2001
Intern
Charles Stark Draper Laboratory Jun 2000 - Dec 2000
Intern
Education:
Boston University 2008 - 2009
Certificate, Management Northeastern University 2005 - 2008
MS, Pharmaceutical Biotechnology Tufts University Sep 1997 - May 2001
BS, Chemical Engineering
Skills:
ELISA
R
Statistics
SharePoint
Linear Regression
Lifesciences
Biotechnology
Assay Development
Molecular Biology
qPCR
Drug Discovery
High Throughput Screening
Immunoassays
Microarray
Microarray Analysis
R Package Development
RT-PCR
Project Management
Principal Component Analysis
Laboratory Automation
Electronic Laboratory Notebook
Cell
Protein Chemistry
Interests:
hiking, soccer, cycling, science history

Publications

Us Patents

Methods Of Assessing Activity Of A Polysaccharide Composition

View page
US Patent:
20120183976, Jul 19, 2012
Filed:
Apr 16, 2010
Appl. No.:
13/264696
Inventors:
He Zhou - Malden MA, US
Jay Duffner - Shirley MA, US
Takashi Kei Kishimoto - Lexington MA, US
Birgit Schultes - Arlington MA, US
International Classification:
G01N 33/566
C12Q 1/06
C12Q 1/37
G01N 33/573
US Classification:
435 724, 435 792, 435 74, 435 39, 435 23, 436501, 435 71
Abstract:
Methods of assessing polysaccharide preparations lacking substantial anticoagulant activity are provided herein.

N-Acetylhexosamine-Containing N-Glycans In Glycoprotein Products

View page
US Patent:
20120295273, Nov 22, 2012
Filed:
Mar 12, 2012
Appl. No.:
13/417895
Inventors:
Nathaniel J. Washburn - Littleton MA, US
Enrique Arevalo - Dorchester MA, US
Kevin Millea - Saugus MA, US
Carlos J. Bosques - Arlington MA, US
Jay Duffner - Shirley MA, US
Brian E. Collins - Arlington MA, US
International Classification:
G01N 33/68
G01N 27/62
G01N 21/25
G01N 30/02
G01N 24/08
G01N 33/53
G01N 21/64
G01N 27/26
US Classification:
435 71, 435 18, 436 87, 435 29
Abstract:
The present invention provides methods of evaluating a glycoprotein preparation for the absence, presence or amount of an N-acetylhexosamine glycan, e.g., an N-acetylglucosamine glycan.

Selection And Use Of Host Cells For Production Of Glycoproteins

View page
US Patent:
20130123126, May 16, 2013
Filed:
Apr 7, 2011
Appl. No.:
13/637972
Inventors:
Brian Edward Collins - Arlington MA, US
Jay Duffner - Shirley MA, US
Victor Farutin - Watertown MA, US
Naveen Bhatnagar - Framingham MA, US
Carlos J. Bosques - Arlington MA, US
Ganesh Kaundinya - Bedford MA, US
Assignee:
MOMENTA PHARMACEUTICALS, INC. - Cambridge MA
International Classification:
C12Q 1/04
G06F 19/00
C12Q 1/68
US Classification:
506 9, 506 10, 707705
Abstract:
A method of making a glycoprotein having a selected glycostructure.

High Mannose Glycans

View page
US Patent:
20130231255, Sep 5, 2013
Filed:
Apr 7, 2011
Appl. No.:
13/637974
Inventors:
Brian Edward Collins - Arlington MA, US
Jay Duffner - Shirley MA, US
Carlos J. Bosques - Arlington MA, US
Dorota A. Bulik - Malden MA, US
James Myette - Waltham MA, US
James Meador - Framingham MA, US
Assignee:
MOMENTA PHARMACEUTICALS, INC. - Cambridge MA
International Classification:
G01N 33/50
C12P 21/00
US Classification:
506 6, 435 691
Abstract:
Methods and compositions related to high mannose glycans are described.

Process For Removing Microbubbles From A Liquid

View page
US Patent:
20070119774, May 31, 2007
Filed:
Jan 11, 2005
Appl. No.:
10/585960
Inventors:
Larry Yen - Andover MA, US
Jay Duffner - Shirley MA, US
Saksatha Ly - Lexington MA, US
International Classification:
B01D 39/14
US Classification:
210500100
Abstract:
A process is provided for removing microbubbles from a liquid by filtration with a composite porous membrane which is formed from a porous polymeric membrane having an average pore size between about 0.01 and 0.03 microns on which is directly coated a cross-linked polymer derived from N,N-methylenebisacrylamide (MBAM) optionally containing dimethylacrylamide (DMAM).

Methods And Compositions For The Diagnosis And Treatment Of Kawasaki Disease

View page
US Patent:
20210116462, Apr 22, 2021
Filed:
Apr 6, 2020
Appl. No.:
16/841575
Inventors:
- Cambridge MA, US
Carlos J. Bosques - Cambridge MA, US
Jay Duffner - Shirley MA, US
Leona E. Ling - Winchester MA, US
Hetal Sarvaiya - Foster City CA, US
International Classification:
G01N 33/68
A61K 31/727
A61K 38/17
A61K 39/395
Abstract:
The present invention relates to the determination of levels or expression of particular biomarkers in biological samples which can be utilized to diagnose, prognose, and treat Kawasaki disease in subjects, and further to select subjects who would benefit from a Kawasaki disease therapy other than, or in addition to, IVIG treatment. Accordingly, the present invention encompasses methods and compositions that utilize these biomarkers for the diagnosis, prognosis, and treatment of Kawasaki disease.

Variant-Specific Alignment Of Nucleic Acid Sequencing Data

View page
US Patent:
20200058375, Feb 20, 2020
Filed:
Feb 23, 2018
Appl. No.:
16/487339
Inventors:
- Cambridge MA, US
Jay Duffner - Cambridge MA, US
International Classification:
G16B 30/10
G16B 30/20
G16B 20/00
Abstract:
Techniques and systems for determining a correct alignment of nucleic acid sequences are described. Determining the correct alignment may include generating multiple reference sequences that include one or more variants and aligning the nucleic acid sequences to the multiple reference sequences. The correct alignment may include performing an alignment of the nucleic acid sequences using the multiple reference sequences and determining the correct alignment for the nucleic acid sequences based at least in part on a result of the alignment using the multiple reference sequences.

Methods And Compositions For The Diagnosis And Treatment Of Kawasaki Disease

View page
US Patent:
20170052200, Feb 23, 2017
Filed:
May 1, 2015
Appl. No.:
15/308114
Inventors:
- Cambridge MA, US
Jay DUFFNER - Shirley MA, US
Leona E. LING - Winchester MA, US
Hetal SARVAIYA - Foster City CA, US
Carlos J. BOSQUES - Arlington MA, US
International Classification:
G01N 33/68
A61K 39/395
A61K 31/727
Abstract:
The present invention relates to the determination of levels or expression of particular biomarkers in biological samples which can be utilized to diagnose, prognose, and treat Kawasaki disease in subjects, and further to select subjects who would benefit from a Kawasaki disease therapy other than, or in addition to, IVIG treatment. Accordingly, the present invention encompasses methods and compositions that utilize these biomarkers for the diagnosis, prognosis, and treatment of Kawasaki disease.
Control profile
Jay L Duffner from Shirley, MA, age ~46 Get Report